Stock indexes in the U.S. rose Monday with the rising 1.86%. Meanwhile, the added 1.23%, and the added 0.71%.

BioMarin Pharmaceutical (Nasdaq: BMRN) missed both revenue and earnings estimates in the third quarter, and yet, shares are ...

Dyne Therapeutics’ stock sees record rally, but one analyst says it could still climb a lot further, after a rival got bought ...

BIO-key® International, Inc. (NASDAQ: BKYI), an innovator in biometric authentication and Identity and Access Management (IAM ...

BridgeBio Pharma shares surge on positive BBP-418 trial results for limb-girdle muscular dystrophy. Read more here.

With U.S. stock markets set to open in two hours, Avidity Biosciences Inc. (RNA) was up 43.6% in pre-market trading, and BridgeBio Pharma Inc. (BBIO) was up 10.6%.

BIO-key International, Inc. (NASDAQ:BKYI) shares soared 180% in premarket trading Monday after the biometric authentication ...

Novartis announces agreement to buy Avidity Biosciences for $12 billion. Here's why NVS is paying such a hefty premium for ...

BIO-key International (NASDAQ: BKYI) shares surge 166% premarket after partnering with IT2Trust to expand GDPR-compliant IAM ...

Investing.com -- BIO-key International, Inc. (NASDAQ:BKYI) stock surged 180% in premarket trading Monday after the biometric authentication provider announced a new partnership with IT2Trust, a major ...

Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, ...

Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases; ...